EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumors.

Saved in:
Bibliographic Details
Title: EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumors.
Authors: Sergeeva OA; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Jin G; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Sarkar M; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Zeiger J; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Dhindwal S; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Chin SS; EvolveImmune Therapeutics, Inc., Branford, CT 06405.; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591., Abulizi A; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Lai Z; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Brown C; EvolveImmune Therapeutics, Inc., Branford, CT 06405., DeMaria WG; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Ryan D; EvolveImmune Therapeutics, Inc., Branford, CT 06405., An X; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Karp HJ; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Teran E; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Yuan C; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Klaskin D; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Reeve TA; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Yu GK; Independent Consultant, Kensington, CA 94708., Tam EM; EvolveImmune Therapeutics, Inc., Branford, CT 06405.; Antibody Technology Fred Hutchinson Cancer Center, Seattle, WA 98109., Kaech SM; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037., Preyer M; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Matis L; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Fine JS; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Martomo SA; EvolveImmune Therapeutics, Inc., Branford, CT 06405., Myers JS; EvolveImmune Therapeutics, Inc., Branford, CT 06405.
Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2025 Nov 25; Vol. 122 (47), pp. e2510829122. Date of Electronic Publication: 2025 Nov 18.
Publication Type: Journal Article
Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41252152
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sergeeva+OA%22">Sergeeva OA</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Jin+G%22">Jin G</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Sarkar+M%22">Sarkar M</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Zeiger+J%22">Zeiger J</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Dhindwal+S%22">Dhindwal S</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Chin+SS%22">Chin SS</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591.<br /><searchLink fieldCode="AU" term="%22Abulizi+A%22">Abulizi A</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Lai+Z%22">Lai Z</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Brown+C%22">Brown C</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22DeMaria+WG%22">DeMaria WG</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Ryan+D%22">Ryan D</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22An+X%22">An X</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Karp+HJ%22">Karp HJ</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Teran+E%22">Teran E</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Yuan+C%22">Yuan C</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Klaskin+D%22">Klaskin D</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Reeve+TA%22">Reeve TA</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Yu+GK%22">Yu GK</searchLink>; Independent Consultant, Kensington, CA 94708.<br /><searchLink fieldCode="AU" term="%22Tam+EM%22">Tam EM</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.; Antibody Technology Fred Hutchinson Cancer Center, Seattle, WA 98109.<br /><searchLink fieldCode="AU" term="%22Kaech+SM%22">Kaech SM</searchLink>; NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037.<br /><searchLink fieldCode="AU" term="%22Preyer+M%22">Preyer M</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Matis+L%22">Matis L</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Fine+JS%22">Fine JS</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Martomo+SA%22">Martomo SA</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.<br /><searchLink fieldCode="AU" term="%22Myers+JS%22">Myers JS</searchLink>; EvolveImmune Therapeutics, Inc., Branford, CT 06405.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227505876%22">Proceedings of the National Academy of Sciences of the United States of America</searchLink> [Proc Natl Acad Sci U S A] 2025 Nov 25; Vol. 122 (47), pp. e2510829122. <i>Date of Electronic Publication: </i>2025 Nov 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22National+Academy+of+Sciences%22">National Academy of Sciences </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7505876 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1091-6490 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200278424%22">00278424 </searchLink><i>NLM ISO Abbreviation: </i>Proc Natl Acad Sci U S A <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41252152
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1073/pnas.2510829122
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e2510829122
    Titles:
      – TitleFull: EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sergeeva OA
      – PersonEntity:
          Name:
            NameFull: Jin G
      – PersonEntity:
          Name:
            NameFull: Sarkar M
      – PersonEntity:
          Name:
            NameFull: Zeiger J
      – PersonEntity:
          Name:
            NameFull: Dhindwal S
      – PersonEntity:
          Name:
            NameFull: Chin SS
      – PersonEntity:
          Name:
            NameFull: Abulizi A
      – PersonEntity:
          Name:
            NameFull: Lai Z
      – PersonEntity:
          Name:
            NameFull: Brown C
      – PersonEntity:
          Name:
            NameFull: DeMaria WG
      – PersonEntity:
          Name:
            NameFull: Ryan D
      – PersonEntity:
          Name:
            NameFull: An X
      – PersonEntity:
          Name:
            NameFull: Karp HJ
      – PersonEntity:
          Name:
            NameFull: Teran E
      – PersonEntity:
          Name:
            NameFull: Yuan C
      – PersonEntity:
          Name:
            NameFull: Klaskin D
      – PersonEntity:
          Name:
            NameFull: Reeve TA
      – PersonEntity:
          Name:
            NameFull: Yu GK
      – PersonEntity:
          Name:
            NameFull: Tam EM
      – PersonEntity:
          Name:
            NameFull: Kaech SM
      – PersonEntity:
          Name:
            NameFull: Preyer M
      – PersonEntity:
          Name:
            NameFull: Matis L
      – PersonEntity:
          Name:
            NameFull: Fine JS
      – PersonEntity:
          Name:
            NameFull: Martomo SA
      – PersonEntity:
          Name:
            NameFull: Myers JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 11
              Text: 2025 Nov 25
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1091-6490
          Numbering:
            – Type: volume
              Value: 122
            – Type: issue
              Value: 47
          Titles:
            – TitleFull: Proceedings of the National Academy of Sciences of the United States of America
              Type: main
ResultId 1